Tibremciclib or Placebo Plus Fulvestrant in Hormone Receptor-Positive and ERBB2-Negative Advanced Breast Cancer After Endocrine Therapy: A Randomized Clinical Trial
替布西尼或安慰剂联合氟维司群治疗内分泌治疗后激素受体阳性、ERBB2阴性晚期乳腺癌:一项随机临床试验
期刊:Jama Oncology
影响因子:20.1
doi:10.1001/jamaoncol.2025.2092
Tao, Zhonghua; Zhang, Jian; Zheng, Qiufan; Wang, Yongsheng; Cai, Li; Xu, Hongyan; Xu, Xinhua; Kong, Xiangshun; Ding, Sijuan; Hao, Chunfang; Wang, Hao; Zong, Hong; Jin, Xin; Wang, Xinshuai; Li, Yang; Yang, Xiuli; Li, Weijie; Du, Xiaoya; Chen, Hui; Wu, Pengxiang; Li, Peiqi; Mao, Li; Ding, Lieming; Hu, Xichun; Wang, Shusen